[Elsevier] Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study |
|
This post will be closed automatically in 2026-10-20 10:02
Reward10points
|
10
Advances in high pressure processing of fruit and vegetable juices
10
Grinding and milling (mechanochemical) methods: An excellent greener approach to develop sustainable materials
10
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
10
Materials: types and general classifications
